Free Trial

Xilio Therapeutics (XLO) SEC Filings & 10K Form

Xilio Therapeutics logo
$0.94 -0.08 (-7.83%)
(As of 11/20/2024 ET)

Recent Xilio Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
4:44 PM
Bain Capital Life Sciences Fund II, L.P. (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:50 PM
Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
11/12/2024
9:40 AM
FMR LLC (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
11/07/2024
8:25 AM
Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
8:20 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
8:36 PM
GKCC, LLC (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G
09/27/2024
8:00 PM
Chudnovsky Yekaterina (Reporting)
GKCC, LLC (Reporting)
Xilio Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2024
6:45 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:51 AM
Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
7:00 PM
Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
6:46 AM
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
06/17/2024
3:30 PM
Curran Daniel J. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
Clancy Paul J (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
Rossi Christina (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
ROSS ROBERT W. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
Bonstein Sara (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
Xilio Therapeutics (Issuer)
Xu Yuan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:09 AM
Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
6:45 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
11:15 PM
Xilio Therapeutics (Filer)
Form EFFECT
04/30/2024
4:09 PM
Xilio Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/15/2024
8:00 AM
Xilio Therapeutics (Filer)
Form 424B5
04/05/2024
3:31 PM
GILEAD SCIENCES, INC. (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G
04/05/2024
1:51 PM
Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
04/03/2024
5:48 PM
GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
5:50 PM
GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:15 PM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
3:20 PM
Xilio Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
3:08 PM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
6:55 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:12 PM
Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G
02/09/2024
3:33 PM
Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:01 PM
Octagon Capital Advisors LP (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
01/19/2024
3:30 PM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
5:16 PM
Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
3:38 PM
Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
3:15 PM
Russo Rene (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
3:15 PM
Brennan Kevin M. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
3:15 PM
Luptakova Katarina (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
6:45 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:XLO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners